Clinical Trial Update: A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating tirzepatide in pediatric and adolescent participants with Type 2 Diabetes Mellitus inadequately controlled with metformin or basal in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Tirzepatide (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type2 Diabetes, Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2025-09-26